Oxford Cannabinoid Techn... Share Discussion Threads

[itscominghome] 11/4/2023 13:07

Looking to have a position long 20m eventually

[itscominghome] 11/4/2023 13:06

Bought 5m of these over the last week.

[oscar nosher] 03/4/2023 12:57

Ever wondered why the conman that hides behind the Zxie alias gets recommendations for writing shyte ?
It?s because he uses his aliases
- mr woodland
- moor sir
to recommend his posts
DIRTY FILTHY SCAMMER

[zxie] 03/4/2023 08:25

https://twitter.com/clarissamapson/status/1641771719491743747?s=46&t=D5m9d8QJFGkeuiy-jL6_TQ

[zxie] 03/4/2023 08:24

Moving 2p next

[zxie] 31/3/2023 10:35

This Phase I first-in-human clinical trial, due to commence in Q1 2023, which is being funded entirely from OCTP's existing resources, will be conducted in the UK in healthy volunteers, with a single ascending dose. The trial aims to demonstrate the safety and tolerability of OCT461201, whilst also providing pivotal information on its pharmacokinetic profile, to confirm its value as a potential drug. The clinical trial is anticipated to complete within Q2 2023.

[zxie] 30/3/2023 14:04

Tomorrow RNS

[sweetg] 30/3/2023 13:20

With news being so very long overdue , a day away from the end of Q1 and phase 1 not even started because no sign of approval ,. Without a press release soon with reference to why news of approval status is missing (there is a legality there as the 60 day legal limit after submission past quite a few weeks back now...) this thing risks tanking hard and fast . Just saying.

[zxie] 30/3/2023 10:06

3m buy show red

[zxie] 28/3/2023 17:00

This Phase I first-in-human clinical trial, due to commence in Q1 2023, which is being funded entirely from OCTP's existing resources, will be conducted in the UK in healthy volunteers, with a single ascending dose. The trial aims to demonstrate the safety and tolerability of OCT461201, whilst also providing pivotal information on its pharmacokinetic profile, to confirm its value as a potential drug. The clinical trial is anticipated to complete within Q2 2023.

[zxie] 28/3/2023 14:12

Nice volume today

[gotterdammerung] 28/3/2023 12:57

Clarissa Sowemimo-Coker
@clarissamapson
It’s a huge milestone for us and our shareholders - moving from pre-clinical to clinical is the crucial next step in our journey to put licensed medicines into the hands of patients who need them. #AskOCTP posted 24th march
All to play for now very exciting opportunities on approval.

[pillow] 28/3/2023 12:51

Yep, buyers moving in again.

[zxie] 28/3/2023 12:13

RNS any time

[pillow] 21/3/2023 14:33

News could drop anytime now.. Exciting times ahead.

[zxie] 20/3/2023 11:42

-- Pre-clinical activities for the Company's lead programme, OCT461201 (programme 1), remained on track and on budgeto Phase I clinical trial is due to commence in Q1 2023 with interim results anticipated in Q2 2023

[zxie] 19/3/2023 08:17

This shares Similar to PYC . as long as the result is positive. Easy Jump up 20p

[sweetg] 18/3/2023 10:25

oh the suspense! maybe mon or tues for long overdue news, always seems to be good news at the start of a week (to allow for a sustained rally), or bad news on thurs, so a terrible drop cannot gain pace without the weekend halt to a sustained fall...